This highlights the dual nature of ferroptosis modulation: while inducers target tumor cells, inhibitors protect vital organs and immune cells (e.g., CD8+ T cells vulnerable to oxidative stress), thereby optimizing therapeutic windows [138]. Here, CD8A is linked to neoplasm.